Physician profile
Maureen E Bauer
NPI 1427334366
$15,868.73
in general payments reported to CMS, 2019-2025
4 companies · $5,849 in 2025
The $5,849 reported for 2025 was more than what 85% of Allergy & Immunology providers received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,683 · 2023: $6,271 · 2024: $1,066 · 2025: $5,849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,203 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,504 · Food and Beverage: $395 · Travel and Lodging: $83.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,203.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,504.00 |
| Food and Beverage | $395.43 |
| Travel and Lodging | $83.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $11,503.73 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $3,600.00 | 2023 | Dupixent |
| Dr.Reddy'S Laboratories,INC. | $585.00 | 2023 | |
| Glaxosmithkline, LLC. | $180.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.